WASHINGTON, USA – The Inter-American Development Bank (IDB) announced on December 16, that it will mobilize $1 billion to help Latin American and Caribbean countries acquire and distribute COVID-19 vaccines.
The funds will complement $1.2 billion in resources that the IDB has committed in 2020, as well as other funds already programmed for 2021, to help countries save lives through public-health measures, such as more effective testing and tracing, and better clinical management of COVID-19 patients.
“We are expanding our support to help Latin American and Caribbean countries ensure timely access to safe and effective COVID-19 vaccines,” said IDB president Mauricio Claver-Carone. “The coming months will be critical to altering the course of the pandemic and supporting the recovery of our region, which is why we are being bold and proactive.”
The IDB will support countries in three main areas:
- The purchase of vaccine doses through multilateral efforts, such as the COVAX Facility;
- Institutional strengthening to help countries develop effective vaccine deployment mechanisms; and,
- Investment to build immunization capacity and finance operational costs.
The bank will work closely with other institutions, including the Pan-American Health Organization.
In addition, the IDB is reiterating its call for Latin American and Caribbean governments to redouble efforts to prepare national deployment and vaccination plans. The IDB stands ready to help ensure their successful implementation throughout the region.
For information on the bank’s operational response to COVID-19 across sectors, view the dashboard here. Visit the coronavirus hub here.
